Dysregulation of human beta-defensin-1 (hBD-1) in behcet{u2019}s disease : An association with pathophysiology of the disease / Dalia Fouad Mahmoud Elgibaly ; Supervised Dalia Ahmed Ali Labib , Hala Lotfy Fayed , Aliaa Sayed Eldash
Material type: TextLanguage: English Publication details: Cairo : Dalia Fouad Mahmoud Elgibaly , 2021Description: 119 P. : charts , facsimiles ; 25cmOther title:- فى مرض بهجت (hBD-1)البشرى defensin-1 عدم تنظيم بيتا : رابطة مع الفسيولوجيا المرضية للمرض [Added title page title]
- Issued also as CD
Item type | Current library | Home library | Call number | Copy number | Status | Date due | Barcode | |
---|---|---|---|---|---|---|---|---|
Thesis | قاعة الرسائل الجامعية - الدور الاول | المكتبة المركزبة الجديدة - جامعة القاهرة | Cai01.11.07.M.Sc.2021.Da.D (Browse shelf(Opens below)) | Not for loan | 01010110083803000 | |||
CD - Rom | مخـــزن الرســائل الجـــامعية - البدروم | المكتبة المركزبة الجديدة - جامعة القاهرة | Cai01.11.07.M.Sc.2021.Da.D (Browse shelf(Opens below)) | 83803.CD | Not for loan | 01020110083803000 |
Thesis (M.Sc.) - Cairo University - Faculty of Medicine - Department of Clinical and Chemical Pathology
Background: Behçet's disease (BD) is a multisystem inflammatory disease of unknown etiology. Beta-defensins are antimicrobial peptides involved in epithelial host defense. The purpose of this work is to explore whether beta-defensins might be involved in BD pathogenesis or not in in Egyptian patients. Methodology: This case control study included 40 BD patients fulfilling the criteria of the International Criteria for Behcet's Disease (ICBD), compared to 40 age and sex matched healthy subjects. The -20G/A DEFB1 genotypes were determined by restriction fragment length polymorphism (RFLP) technique and systemic levels of plasma hBD-1 were measured using ELISA technique. Results: Plasma hBD-1 concentration was found to be significantly higher in patients than controls groups (p-value <0.001). No statistical significant difference was found between both groups regarding genotyping of -20G/A DEFB1 gene polymorphism (rs11362), allele frequency. Conclusion: The study findings suggest that hBD-1 is involved in BD pathophysiology, and may be used as a marker for BD and possibly a target for therapeutic intervention
Issued also as CD
There are no comments on this title.